leisure time -WSS

leisure time

author：comprehensive 2025-10-01 21:48:36 - browse：1

Illustration of a teal cancer cell. -- health coverage from STAT — Illustration of a teal cancer cell. Adobe

Sana Biotechnology, a startup that just a couple of years ago raised over $1 billion off a grand plan to create a portfolio of powerful medicines, said Tuesday it would lay off nearly a third of its employees and de-prioritize one of its most ambitious programs as it looks to save money.

The layoffs are Sana’s second round of cuts in less than a year. It laid off 15% of staff last November after axing another program.

Tuesday’s move pushed back a program focused on turning a patient’s own immune cells into cancer-killing assassins or curing blood disorders such as sickle cell with just an IV infusion. Known as in vivo reprogramming, it was originally the company’s central focus and would have amounted to a monumental breakthrough.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： Group opposing PBM reform sets lobbying record

hotspot

explore

WSS

Biogen joins immunology wave with $1.15 billion acquisition of HI

H5N1 bird flu outbreak: Second human case reported, in Michigan

Group opposing PBM reform sets lobbying record

ARCH Venture Partners tops STAT's 2023 biotech VC rankings

Cosmetics set for new safety regulation. Why the industry is on board

Liver decline slowed by off

entertainment

leisure time

hotspot

How to save PrEP access — and even expand it

Scrutiny of post

Wildfire smoke exposes gaps in outdoor worker protections

Cosmetics set for new safety regulation. Why the industry is on board

Peter Hotez and the public health issue of online harassment

Cue Health, Covid

Medical records are filled with copy

Biogen joins immunology wave with $1.15 billion acquisition of HI

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

H5N1 virus can be tracked in retail milk, scientists say

explore

Investigation reveals sickle cell patients pressured into sterilizations

Group opposing PBM reform sets lobbying record

Readout Newsletter: H5N1 bird flu vaccine, Cytokinetics, Gilead

Reports of telehealth's death have been greatly exaggerated

A public scorecard can help hold safety

Readout Newsletter: H5N1 bird flu vaccine, Cytokinetics, Gilead

focus

explore

leisure time

focus